-
MoonLake Immunotherapeutics (NASDAQ:MLTX) Given Average Recommendation of "Moderate Buy" by Analysts
来源: Buzz FX / 23 11月 2024 01:46:08 America/Chicago
MoonLake Immunotherapeutics (NASDAQ:MLTX) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat November 23, 2024 Share Link copied to clipboard. Shares of MoonLake Immunotherapeutics ( NASDAQ:MLTX - Get Free Repo
Read more...